Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Context Therapeutics Inc (NQ: CNTX ) 2.430 -0.020 (-0.82%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Context Therapeutics Inc < Previous 1 2 3 4 5 Next > Context Therapeutics And 3 Other Stocks Under $1 Insiders Are Aggressively Buying January 24, 2023 The Dow Jones closed higher by more than 250 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Myomo, Enzo Biochem And These 2 Stocks Under $2 Insiders Are Aggressively Buying January 19, 2023 The Dow Jones closed lower by more than 600 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Context Therapeutics and Lonza Enter Manufacturing Agreement for Bispecific Antibody Targeting Claudin 6-Positive Cancers January 09, 2023 From Context Therapeutics Inc. Via GlobeNewswire Context Therapeutics® Highlights 2023 Corporate Priorities and Pipeline Milestones January 04, 2023 From Context Therapeutics Inc. Via GlobeNewswire What About Women? This Company Targets Female-Focused Cancers January 31, 2022 Photo sourced from Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Via Benzinga Why Express Shares Are Trading Higher By 39%? Here Are 50 Stocks Moving In Thursday's Mid-Day Session December 08, 2022 Gainers My Size, Inc. (NASDAQ: MYSZ) shares jumped 88% to $0.2839. My Size announced a 1-for-25 reverse stock split. Via Benzinga Why Context Therapeutics Stock Is Falling 25% Today December 08, 2022 Context Therapeutics Inc (NASDAQ: CNTX) shares are trading lower by 26.62% to $1.02 during Thursday's session after the company reported preliminary Phase 2 data for ONA-XR metastatic breast cancer.... Via Benzinga Context Therapeutics® Reports Encouraging Preliminary Phase 2 Data for ONA-XR in Metastatic Breast Cancer December 08, 2022 From Context Therapeutics Inc. Via GlobeNewswire Context Therapeutics® Nominates CTIM-76 Bispecific Antibody Candidate to Develop Treatment for Claudin 6-Positive Solid Tumors November 29, 2022 From Context Therapeutics Inc. Via GlobeNewswire Context Therapeutics® Announces Clinical Updates on ONA-XR to be Presented at 2022 San Antonio Breast Cancer Symposium November 21, 2022 Company reports initial ONA-XR data from the ongoing Phase 2 SMILE trial for metastatic breast cancer will be presented From Context Therapeutics Inc. Via GlobeNewswire Context Therapeutics Partners With Integral Molecular To Develop An Emerging Cancer Drug November 10, 2022 Context Therapeutics Inc. (NASDAQ: CNTX) and Integral Molecular are teaming up to develop an anti-claudin 6 (CLDN6) bispecific monoclonal antibody (BsMAb) for cancer therapy. Via Benzinga Context Therapeutics® Reports Third Quarter 2022 Operating and Financial Results November 09, 2022 From Context Therapeutics Inc. Via GlobeNewswire New Ammo In The Battle Against Cancer – Context Therapeutics Sees Promising Results For Several Novel Drugs August 17, 2022 Martin Lehr, Co-Founder and CEO of Contect Therapeutics, Inc (NASDAQ: CNTX), was a guest on Benzinga’s All Access on Aug 12, 2022. Via Benzinga 69 Biggest Movers From Friday June 06, 2022 Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per... Via Benzinga 40 Stocks Moving In Friday's Mid-Day Session June 03, 2022 Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share. Via Benzinga 35 Stocks Moving In Monday's Mid-Day Session April 04, 2022 Gainers Aterian, Inc. (NASDAQ: ATER) shares jumped 43.5% to $3.3457. Aterian said Cynthia Williams has joined the Company's Board of Directors. Jumia Technologies AG (... Via Benzinga 66 Biggest Movers From Friday May 23, 2022 Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday April 04, 2022 If you're looking for the biggest pre-market stock movers for Monday, we've got you covered with a list of gainers and losers for today. Via InvestorPlace 68 Biggest Movers From Yesterday April 05, 2022 Gainers GBS Inc. (NASDAQ: GBS) jumped 68% to settle at $1.31 on Monday. Zacks Small-Cap Research issued a note on GBS with an $8 valuation. Aterian, Inc. (NASDAQ: ATER) shares... Via Benzinga 26 Stocks Moving in Monday's Pre-Market Session April 04, 2022 Gainers SPI Energy Co., Ltd. (NASDAQ: SPI) rose 36.3% to $3.87 in pre-market trading after reporting record revenue of $162 million for 2021. Twitter, Inc. (NYSE: TWTR) rose... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022 February 02, 2022 Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09... Via Benzinga 45 Biggest Movers From Yesterday December 29, 2021 Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares climbed 64.8% to close at $19.02 on Tuesday as traders circulated a social media post on a potential short squeeze. ShiftPixy... Via Benzinga 25 Stocks Moving In Tuesday's Mid-Day Session December 28, 2021 Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 64.6% to $18.99 as traders circulated a social media post on a potential short squeeze. Flotek Industries, Inc. (NYSE... Via Benzinga 32 Stocks Moving In Wednesday's Mid-Day Session December 22, 2021 Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares surged 31.7% to $2.41 after the company announced it was awarded a multiple award blanket purchase agreement by the United... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday December 22, 2021 We've reached the halfway point of the week and we're starting it with an overview of the biggest pre-market stock movers for Wednesday! Via InvestorPlace 20 Stocks Moving in Wednesday's Pre-Market Session December 22, 2021 Gainers BioRestorative Therapies, Inc. (NASDAQ: BRTX) rose 48.1% to $6.77 in pre-market trading after the company entered into a Master Service Agreement with PRC Clinical,... Via Benzinga 58 Biggest Movers From Yesterday December 14, 2021 Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-... Via Benzinga 40 Stocks Moving In Monday's Mid-Day Session December 13, 2021 Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction.... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday December 13, 2021 Welcome back, investor! With our return from the weekend comes a dive into the biggest pre-market stock movers for Monday! Via InvestorPlace 22 Stocks Moving in Monday's Pre-Market Session December 13, 2021 Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 32.6% to $3.58 in pre-market trading after gaining more than 14% on Friday. Foghorn Therapeutics Inc. (NASDAQ: FHTX) rose... Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.